Section F‑IV, 4.13, in the Guidelines for Examination in the EPO applies mutatis mutandis.[GL/ISPE 5.21; 5.23; ]
For claims directed to a known substance or composition for use in a surgical, therapeutic or diagnostic method, see GL/PCT‑EPO G‑II, 4.2.
Source: http://www.epo.org/law-practice/legal-texts/html/guidelinespct/e/f_iv_4_13.htm
Date retrieved: 17 May 2021